rituximab,acalabrutinib,bendamustine
astrazeneca
['acalabrutinib', 'mantle,(-dismantle)', 'bendamustine', 'rituximab', 'lymphoma', 'ritux', 'lymsm']
acalabrutinib, bendamustine, &amp; rituximab showed tolerability and promising efficacy for patients with treatment-naive or r/r mantle cell lymphoma. #eha2023 #mcl #lymsm | 
Oncology news and insights from leading researchers and cancer centers.